| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |